Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Clinical trial NCT01707264 · COMPLETED

Trial details

NCT number: NCT01707264
Sponsor: Prothena Biosciences Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Amyloidosis

Start date: 2013-04-01
Primary completion: 2016-08-09
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.